ADVERTISEMENT



HEALTHCARE

Thousands benefited from Hepatitis campaign

September 26, 2018

Thousands benefited from Hepatitis campaign

KUWAIT: Director of media office at the ministry of health Dr Galiah Al-Mutairi said yesterday that more than 20,000 people benefited from Hepatitis awareness campaign in its three phases. This came during an awareness lecture organized by the ministry of health in coordination with ministry of interiors about Hepatitis Virus at Saad Al-Abdullah Academy for Security Sciences as part of the third phase of"... Continue Reading

MoH to accept pharmacists with no practical experience

September 25, 2018

MoH to accept pharmacists with no practical experience

KUWAIT CITY, Sept 24, (KUNA): Kuwaiti Minister of Health Sheikh Dr Bassel Al-Sabah issued on Monday three decisions, the first approving employment of pharmacists with illegal residency and children of Kuwaiti women with no practical experience.

A press"... Continue Reading

Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib

September 23, 2018

Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib

(AETOS Wire) -- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG®(brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If the CHMP opinion is affirmed, and the European Commission approves ALUNBRIG, it will become the only ALK inhibitor available in the European Union as a one tablet per day dose that can be taken with or without food....... Continue Reading

“Man of The Planet” Sergey Burlakov Visits Dubai Sports Medicine Facility

September 20, 2018

“Man of The Planet” Sergey Burlakov Visits Dubai Sports Medicine Facility

Sergey Burlakov, a Paralympic athlete and four-time amputee, visited nanoM on September 16th. nanoM is a sports and human performance facility that is the first of its kind in the world, and Burlakov visited to undergo a series of tests.

Karan Rekhi, Vice President - Operations of Emirates Healthcare, said, “An inspirational"... Continue Reading

Kuwait to witness new shift in health insurance sector

September 19, 2018

Kuwait to witness new shift in health insurance sector

Kuwait will witness a new shift in the health services sector as the compulsory health insurance for expatriates will move from the Ministry of Health to Daman company as the company will keep pace with the development plan of the state, says Ahmad Al Saleh, Board Member and CEO of Health Insurance Hospitals.

Al-Saleh said in an"... Continue Reading

175 Million Europeans Have Sleep Apnoea, Highlighting Scale of Global Health Crisis

September 19, 2018

175 Million Europeans Have Sleep Apnoea, Highlighting Scale of Global Health Crisis

(AETOS Wire)-- Roughly 175 million Europeans have obstructive sleep apnoea, according to a late-breaking abstract presented by ResMed today at the European Respiratory Society’s annual ERS Congress in Paris. Leading researchers estimate 90 million Europeans have moderate to severe sleep apnoea, meaning they experience at least 15 breathing events an hour during"... Continue Reading

Hospital contractor in dispute with MoH for reassigning another contractor

September 18, 2018

Hospital contractor in dispute with MoH for reassigning another contractor

The contractor of Jaber Hospital is engaged in a dispute with Ministry of Health and the Ministry of Public Works for reassigning another contractor to supply and install medical equipment, reports Al-Jarida daily.

The daily quoting sources pointed out that the new contractor demolished some walls at the hospital in a primitive"... Continue Reading

No delays over new hospital in Kuwait: health minister

September 17, 2018

No delays over new hospital in Kuwait: health minister

The construction of a new sprawling medical facility in Kuwait is running on schedule, Kuwait’s Health Minister Dr Basel Al-Sabah said yesterday, allaying concerns over alleged delays impeding the project. The minister’s remarks came as he toured the Jaber Al-Ahmad hospital, where he was joined by a number of senior officials.

As"... Continue Reading

Large European real-world study reports effects of Spiolto® Respimat® for people living with COPD in daily clinical practice1

September 17, 2018

Large European real-world study reports effects of Spiolto® Respimat® for people living with COPD in daily clinical practice1

(AETOS Wire)-- Boehringer Ingelheim announced results from the OTIVACTO study, an observational European real-world study of 7,443 Chronic Obstructive Pulmonary Disease (COPD) patients treated with Spiolto® (tiotropium/olodaterol) Respimat®, which were presented today at the European Respiratory Society (ERS) International Congress 2018 in Paris, France.1"... Continue Reading

MEDTEX: Foresee the Next Wave of Healthcare Revolution

September 17, 2018

MEDTEX: Foresee the Next Wave of Healthcare Revolution

(AETOS Wire)-- Taiwan, with high quality medical service and world’s top IT industry, has becoming one of the leaders in global healthcare technology and provider. On November 29 - 30, MEDTEX will focus on 3 key trends: Intelligent Healthcare, Next-generation Biotherapeutics, and Bio-Innovation. Jointed by over 30 world-renowned experts.

At"... Continue Reading

Found articles: - Pages